A Study of LY3841136 in Japanese Participants With Obesity or Overweight

Summary

The main purpose of this study is to learn about the side effects of LY3841136 alone and in combination with tirzepatide, when given to Japanese participants with obese or overweight. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. Part A of the study will last about 28 weeks and may include up to 17 visits. Part B of the study will last about 40 weeks and may include up to 29 visits.

Timeline

Start

2024-04-15

Primary completion

2025-11-21

Completion

2025-11-21

Drugs

Indications